Virtual Network's Login.
The goals of this conference are to define ageing in biological terms, to illustrate the unique aspects of treatment related to ageing, and to practically address treatment issues in the different types of haematological malignancies, including treatments like allogeneic stem cell transplantation.
|
Friday, July 2, 2010 |
||
| 09h00 | Welcome | |
| 09h15 - 10h00 | Opening conference: A panorama on ageing: anaemia in the elderly | L. Balducci (Tampa) |
|
I. Ageing: physiology and pathophysiology |
||
| 10h00 - 10h30 | Epidemiology of ageing in Europe and in the world: clinical and social consequences |
A.J. Cruz-Jentoft (Madrid) |
| 10h30 - 11h00 | Biology of ageing |
I. Irminger-Finger (Geneva) |
| 11h00 - 11h30 | Coffee break | |
| 11h30 - 12h00 | The ageing bone marrow | C. Franceschi (Bologna) |
| 12h00 - 14h00 | Lunch | |
|
II. Clinical evaluation of older persons |
||
| 14h00 - 14h30 | Life expectancy and frailty | M. Rainfray (Bordeaux) |
| 14h30 - 15h00 | Comorbidity, polymorbidity and polypharmacy | G. Gambassi (Rome) |
| 15h00 - 15h30 | Functional assessment of the elderly | M. Barbagallo (Palermo) |
| 15h30 - 16h00 | Pharmacology of ageing | C. Léger-Falandry (Lyon) |
| 16h00 - 16h30 | Coffee break | |
|
III. Myelotoxicity of chemotherapy in the elderly person |
||
| 16h30 - 17h00 | Ageing and marrow depression | L. Balducci (Tampa) |
| 17h00 - 17h20 | Infections in elderly patients with haematological malignancies | L. Balducci (Tampa) |
| 17h20 - 18h30 | Manned Poster Session | |
| 19h30 | Welcome cocktail | |
| 20h00 |
Dinner |
|
|
Saturday, July 3, 2010 |
||
|
IV. MDS and acute leukaemia in the elderly |
||
| 08h30 - 09h00 | MDS: a disease of very elderly patients | R. Stauder (Innsbruck) |
| 09h00 - 09h30 | Treatment of anaemia of lower risk MDS in the elderly: transfuse or prevent anaemia? |
P. Fenaux (Paris) |
| 09h30 - 10h00 | Hypomethylating agents and chemotherapy in higher risk MDS in the elderly: up to what age? |
P. Fenaux (Paris) |
| 10h00 - 10h30 | Quality of life and functional tests in elderly patients with MDS: an important part of treatment endpoints |
O. Beyne-Rauzi (Toulouse) |
| 10h30 - 11h00 | Coffee break | |
| 11h00 - 11h30 | The role of iron chelation therapy in elderly patients with MDS | C. Rose (Lille) |
| 11h30 - 12h00 | Biology of AML in the elderly | A. Renneville (Lille) |
| 12h00 - 12h30 | Management of AML in the elderly | C. Gardin (Paris) |
| 12h30 - 13h00 | Biology and treatment of ALL in the elderly | A. Delannoy (Brussels) |
| 13h00 - 14h30 | Lunch | |
|
V. Myeloma and monoclonal gammopathies diagnosis and prognosis |
||
| 14h30 - 15h00 | Monoclonal gammopathies and multiple myeloma: diagnostic criteria and prognostic factors |
J. Blade (Barcelona) |
| 15h00 - 15h30 | Are current concepts in the treatment of multiple myeloma useful in elderly patients? | J.-L. Harousseau (Nantes) |
| 15h30 - 16h00 | Treatment of multiple myeloma in the elderly | T. Facon (Lille) |
| 16h00 - 16h30 | Prophylaxis and management of toxicities induced by novel agents | M. Delforge (Belgium) |
| 16h30 - 17h00 | Coffee Break | |
| 17h00 - 17h30 | Special lecture: The caregiver of the older aged person | L. Balducci (Tampa) |
| 17h30 - 18h00 | Helping the patient: how to focus on the real problems after cancer treatment | F. Pein (Nantes) |
| 18h00 - 19h00 | Manned Poster Session 2 | |
| 20h00 | Dinner | |
|
Sunday, July 4, 2010 |
||
|
VI. Aggressive lymphoma in the elderly |
||
| 08h30 - 09h00 | Diffuse large B-cell lymphoma in the elderly | pending |
| 09h00 - 09h30 | Hodgkin’s disease in the elderly | pending |
|
VII. Chronic lymphoproliferative disorders in the elderly |
||
| 09h30 - 10h00 | Indolent lymphoma in the elderly |
C. Buske (Ulm) |
| 10h00 - 10h30 | Treatment of CLL in the elderly | V. Levy (Paris) |
| 10h30 - 11h00 | Coffee break | |
|
VIII. Chronic myeloproliferative neoplasms in the elderly |
||
| 11h00 - 11h30 | CML in the elderly | P. Rousselot (Versailles) |
| 12h00 - 12h30 | Other MPN | J.J. Kiladjian (Paris) |
|
IV. Allogeneic stem cell transplantation in elderly patients: is it feasible and effective? |
||
| 12h30 - 13h00 | J. Apperley (London) | |
| Meeting Closure | ||
